Everyone responds differently when they stop taking their medication, Adeyemo says
Clinical trials show that patients typically regain about two-thirds of their lost weight within a year of stopping treatment
Semaglutides, and other GLP-1 medications like them, help promote feelings of satiety that reduce appetite and help prevent overeating Semaglutide Options on the Market The three most common name-brand semaglutide-based GLP-1 medications available are Ozempic, Wegovy, and Ryblesus, and all three drugs are manufactured by Novo Nordisk, a Danish pharmaceutical company
Note from Healthy For Life Meals: If you are taking a GLP-1 receptor agonist and want help making good food choices, consider trying a healthy diet meal delivery program like Healthy For Life Meals
Some people who cannot tolerate tirzepatide find semaglutide more manageable, likely because the absence of GIP receptor activation changes the overall gastrointestinal response
